First Time Loading...

Centessa Pharmaceuticals PLC
NASDAQ:CNTA

Watchlist Manager
Centessa Pharmaceuticals PLC Logo
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Watchlist
Price: 9.47 USD -0.84% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

CNTA Price Targets Summary
Centessa Pharmaceuticals PLC

Wall Street analysts forecast CNTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNTA is 13.87 USD with a low forecast of 8.08 USD and a high forecast of 21 USD.

CNTA Lowest Forecast
Wall Street Target
8.08 USD
15% Downside
CNTA Average Forecast
Wall Street Target
13.87 USD
46% Upside
CNTA Highest Forecast
Wall Street Target
21 USD
122% Upside
Lowest
Price Target
8.08 USD
15% Downside
Average
Price Target
13.87 USD
46% Upside
Highest
Price Target
21 USD
122% Upside
Centessa Pharmaceuticals PLC Competitors:
Price Targets
KOD
Kodiak Sciences Inc
15% Upside
IGMS
IGM Biosciences Inc
115% Upside
300639
Guangdong Hybribio Biotech Co Ltd
540% Upside
X
688278
Xiamen Amoytop Biotech Co Ltd
28% Upside
KOD
Kodiak Sciences Inc
15% Upside
IGMS
IGM Biosciences Inc
115% Upside
300639
Guangdong Hybribio Biotech Co Ltd
540% Upside
X
688278
Xiamen Amoytop Biotech Co Ltd
28% Upside
BBIO
BridgeBio Pharma Inc
82% Upside
PHM
Pharma Mar SA
70% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
33% Upside
2256
Abbisko Cayman Ltd
150% Upside

Revenue
Forecast

Revenue Estimate
Centessa Pharmaceuticals PLC

The compound annual growth rate of Centessa Pharmaceuticals PLC's revenue for the next 3 years is 84%.

N/A
Past Growth
84%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Centessa Pharmaceuticals PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Centessa Pharmaceuticals PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
What are analyst estimates?

See Also

Summary
CNTA intrinsic value, competitors valuation, and company profile.
DCF Valuation
CNTA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CNTA stock valuation using valuation multiples.
Wall Street Estimates
CNTA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CNTA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CNTA's stock price target?
Price Target
13.87 USD

According to Wall Street analysts, the average 1-year price target for CNTA is 13.87 USD with a low forecast of 8.08 USD and a high forecast of 21 USD.

What is Centessa Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
84%

The compound annual growth rate of Centessa Pharmaceuticals PLC's revenue for the next 3 years is 84%.

ALPHA SPREAD
Join more than 134,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.